Public, NASDAQ:HGSI
NASDAQ Global Market
Human Genome Sciences Inc (HGSI) completely dumped by Tradeworx Inc.
Date: Thu, 17 Jul 2008 12:43:01 GMT
Tags:
Human Genome Sciences Inc (HGSI) completely dumped by Tradeworx Inc.
Mffais.com - Jul 17, 2008
Mffais.com - Jul 17, 2008
LONG BEACH ( Mffais . com ) - Tradeworx Inc . completely dumped all - 52,060 shares they owned of Human Genome Sciences Inc ( HGSI ) as shown by filings made public on 2008 - 07 - 16.The stock ...
Human Genome Sciences Inc. - SWOT Analysis - New Research Report on Companies and Markets
Date: Wed, 02 Jul 2008 21:42:53 GMT
Tags:
Human Genome Sciences Inc. - SWOT Analysis - New Research Report on Companies and Markets
PR-Inside.com (Pressemitteilung) - Jul 2, 2008
PR-Inside.com (Pressemitteilung) - Jul 2, 2008
Human Genome Sciences Inc . Company Profile is the essential source for top - level company data and information.The report examines the company ' s key business structure and operations , history ...
2008-07-02 16:13:16 - www.companiesandmarkets.com adds new report - Premium Company Profile - Human Genome Sciences
Date: Wed, 02 Jul 2008 14:16:20 GMT
Tags:
2008-07-02 16:13:16 - www.companiesandmarkets.com adds new report - Premium Company Profile - Human Genome Sciences
PR-Inside.com (Pressemitteilung) - Jul 2, 2008
PR-Inside.com (Pressemitteilung) - Jul 2, 2008
HGS has a broad portfolio of product candidates which are under clinical development for use in large therapeutic categories including immunology , infectious disease and oncology.The company ...
Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
Date: Fri, 13 Jun 2008 03:43:22 GMT
Tags:
Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
RedOrbit - Jun 13, 2008
RedOrbit - Jun 13, 2008
ng statements , which speak only as of today's date.Human Genome Sciences undertakes no obligation to update or revise the information contained in this announcement whether as a result of new ...
Human Genome Sciences reports positive long-term data for LymphoStat-B - Update
Date: Thu, 12 Jun 2008 17:06:02 GMT
Tags:
Human Genome Sciences reports positive long-term data for LymphoStat-B - Update
RTT News - Jun 12, 2008
RTT News - Jun 12, 2008
( RTTNews ) - Thursday , Human Genome Sciences Inc . ( HGSI : News , Chart , Quote ) , a biopharmaceutical company , disclosing results from a long term Phase 2 study of LymphoStat - B or belimumab ...
Human Genome reports positive results from long- term Phase 2 continuation trial of LymphoStat-B - quick facts - RTT NewsHuman Genome Risks Balanced (Zacks.com)
Date: Fri, 18 Jul 2008 15:15:34 Etc/GMT
Tags:
We believe the risk/reward is balanced for HGSI at this point. Therefore, we maintain our Hold rating.
Bioterrorism: Anthrax and Biotech Companies (at Seeking Alpha)
Date: Tue, 17 Jun 2008 09:21:24 Etc/GMT
Tags:
Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus (PR Newswire)
Date: Thu, 12 Jun 2008 11:00:00 Etc/GMT
Tags:
Human Genome Sciences, Inc. today announced the presentation of results from a long- term Phase 2 continuation trial showing that LymphoStat-B® was associated with sustained improvement in disease activity across multiple clinical measures, decreased frequency of disease flares, potential steroid- sparing activity, and was generally well tolerated through three years on treatment in combination with standard of care in patients with serologically active systemic lupus erythematosus .
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Goldman Sachs Conference (PR Newswire)
Date: Mon, 9 Jun 2008 12:00:00 Etc/GMT
Tags:
Sequenom, Royale Energy and OMNI Energy Services lead small-cap volume in pre-market (SmallCapInvestor.com)
Date: Wed, 4 Jun 2008 13:45:29 Etc/GMT
Tags:
Here are the most actively traded companies among small caps: